Immunohistochemical detection of human basophils in late-phase skin reactions

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 3, 1998, Pages 354-362

  Irani, Anne Marie A ^a   Huang, Candice ^b   Xia, Han Zhang ^c   Kepley, Christopher ^a   Nafie, Ala ^a   El Fouda, Desouki ^b   Craig, Shirley ^c   Zweiman, Burton ^a   Schwartz, Lawrence B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b AL AZHAR UNIVERSITY   (Egypt)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Basophil; Endothelial cell; Factor VIII; Mast cell; Tryptase

Indexed keywords

ALLERGY; ARTICLE; BASOPHIL; CELL INFILTRATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAST CELL; PRIORITY JOURNAL; SKIN BIOPSY; SKIN MANIFESTATION; STAINING;

EID: 0031896982     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70248-9     Document Type: Article

References (63)

1. Maruyama N, Tamura G, Aizawa T, Ohrui T, Shimura S, Shirato K, et al. Accumulation of basophils and their chemotactic activity in the airways during natural airway narrowing in asthmatic individuals. Am J Respir Crit Care Med 1994;150:1086-93.
2. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25-9.
3. Zeiger RS, Heller S. Development of nasal basophilic cells and nasal eosinophils from age 4 months through 4 years in children of atopic parents. J Allergy Clin Immunol 1993;91:723-34.
4. Shalit M, Schwartz LB, Golzar N, vonAllman C, Valenzano M, Fleekop P, et al. Release of histamine and tryptase in vivo after prolonged cutaneous challenge with allergen in humans. J Immunol 1988;141:821-6.
5. Charlesworth EN, Hood AF, Soter NA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 1989:83:1519-26.
6. DeShazo RD, Levinson AI, Dvorak HF, Davis RW. The late phase skin reaction: evidence for activation of the coagulation system in an IgE-dependent reaction in man. J Immunol 1979; 122:692-8.
7. Solley GO, Gleich GJ, Jordon RE, Schroeter AL. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest 1976;58:408-20.
8. Kepley CL, Craig SS, Schwartz LB. Identification and partial characterization of a unique marker for human basophils. J Immunol 1995:154:6548-55.
9. Irani AA. Tissue and developmental variation of protease expression in human mast cells. In: Caughey GH, editor. Mast cell proteases in immunology and biology. New York: Marcel Dekker; 1995. p. 127-44.
10. Castells MC, Irani AM, Schwartz LB. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol 1987;138: 2184-9.
11. Xia H-Z, Kepley CL, Sakai K, Chelliah J, Irani A-MA, Schwartz LB. Quantitation of tryptase, chymase, FcεRIα, and FcεRIγ mRNAs in human mast cells and basophils by competitive reverse transcriptionpolymerase chain reaction. J Immunol 1995;154:5472-80.
12. TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and antichymase antibodies. J Histochem Cytochem 1989;37:1509-15.
13. Koshino T, Aral Y, Miyamoto Y, Sano Y, Itami M, Teshima S, et al. Airway basophil and mast cell density in patients with bronchial asthma: relationship to bronchial hyperresponsiveness. J Asthma 1996:33:89-95.
14. Koshino T, Teshima S, Fukushima N, Takaishi T, Hirai K, Miyamoto Y, et al. Identification of basophils by immunohistochemistry in the airways of post-mortem cases of fatal asthma. Clin Exp Allergy 1993:23:919-25.
15. Agis H, Beil WJ, Bankl HC, Füreder W, Sperr WR, Ghannadan M, et al. Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotyping. Leuk Lymphoma 1996:22:187-204.
16. Choi KL, Claman HN. Mast cells, fibroblasts, and fibrosis. New clues to the riddle of mast cells. Immunol Res 1987;6:145-52.
17. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, et al. High-affinity IgE receptor on eosinophils is involved in defense against parasites. Nature 1994:367:183-6.
18. Wang B, Rieger A, Kilgus O, Ochiai K, Maurer D, Fodinger D, et al. Epidermal Langerhans cells from normal human skin bind monomeric IgE via FcεRI. J Exp Med 1992;175:1353-65.
19. Bieber T, Salle H, Wollenberg A, Hakimi J, Chizzonite R, Ring J, et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (FcεRI). J Exp Med 1992; 175:128590.
20. Maurer D, Fiebiger E, Ebner C, Reininger B, Fischer GF, Wichlas S, et al. Peripheral blood dendritic cells express FcεRI as a complex composed of FcεRIα- and FcεRIγ-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 1996:157:607-16.
21. Maurer D, Fiebiger E, Reininger B, Wolff-Winiski B, Jouvin M-H, Kilgus O, et al. Expression of functional high affinity immunoglobulin E receptors (FcεRI) on monocytes of atopic individuals. J Exp Med 1994:179:745-50.
22. Ackerman SJ, Kephart GM, Habermann TM, Greipp PR, Gleich GJ. Localization of eosinophil granule major basic protein in human basophils. J Exp Med 1983;158:946-61.
23. Abu-Ghazaleh RI, Dunnette SL, Loegering DA, Checkel JL, Kita H, Thomas LL, et al. Eosinophil granule proteins in peripheral blood granulocytes. J Leukocyte Biol 1992;52:611-8.
24. Valent P, Majdic O, Maurer D, Bodger M, Muhm M, Bettelheim P. Further characterization of surface membrane structures expressed on human basophils and mast cells. Int Arch Allergy Appl Immunol 1990;91:198-203.
25. Bodger MP, Mounsey GL, Nelson J, Fitzgerald PH. A monoclonal antibody reacting with human basophils. Blood 1987:69:1414-8.
26. Nilsson G, Forsberg K, Bodger MP, Ashman LK, Zsebo KM, Ishizaka T, et al. Phenotypic characterization of stem cell factordependent human foetal liver-derived mast cells. Immunology 1993; 79:325-30.
27. Talbot SF, Atkins PC, Valenzano M, Zweiman B. Correlations of in vivo mediator release with late cutaneous allergic responses in humans 1. Kinetics of histamine release. J Allergy Clin Immunol 1984;74:819-26.
28. Kepley C, Craig S, Schwartz L. Purification of human basophils by density and size alone. J Immunol Methods 1994;175:l-9.
29. Zweiman B, Atkins PC, von Allmen C, Gleich GJ. Release of eosinophil granule proteins during IgE-mediated allergic skin reactions. J Allergy Clin Immunol 1991;87:984-92.
30. Dvorak AM, Warner JA, Fox P, Lichtenstein LM, MacGlashan DW. Recovery of human basophils after FMLP-stimulated secretion. Clin Exp Allergy 1996;26:281-94.
31. Butterfield JH, Weiler D, Peterson EA, Gleich GJ, Leiferman KM. Sequestration of eosinophil major basic protein in human mast cells. Lab Invest 1990;62:77-86.
32. Schwartz LB, Atkins PC, Bradford TR, Fleekop P, Shalit M, Zweiman B. Release of tryptase together with histamine during the immediate cutaneous response to allergen. J Allergy Clin Immunol 1987;80:850-5.
33. Hirai K, Morita Y, Misaki Y, Ohta K, Takaishi T, Suzuki S, et al. Modulation of human basophil histamine release by hemopoietic growth factors. J Immunol 1988;141:3958-64.
34. Hirai K, Yamaguchi M, Misaki Y, Takaishi T, Ohta K, Morita Y, et al. Enhancement of human basophil histamine release by interleukin 5. J Exp Med 1990;172:1525-8.
35. Bischoff SC, Brunner T, De Weck AL, Dahinden CA. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med 1990:172:1577-82.
36. Bischoff SC, Dahinden CA. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 1992;79:2662-9.
37. desarg retains basophil-activating properties. Eur J Immunol 1994;24:1583-9.
38. Hirai K, Miyamasu M, Yamaguchi M, Nakajima K, Ohtoshi T, Koshino T, et al. Modulation of human basophil histamine release by insulin-like growth factors. J Immunol 1993;150:1503-8.
39. Massey WA, Randall TC, Kagey-Sobotka A, Warner JA, MacDonald SM, Gillis S, et al. Recombinant human IL-1α and -1β potentiate IgE-mediated histamine release from human basophils. J Immunol 1989;143:1875-80.
40. Sampson HA, Broadbent KR, Bernhisel-Broadbent J. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity [see comments]. N Engl J Med 1989;321:228-32.
41. James JM, Kagey-Sobotka A, Sampson HA. Patients with severe atopic dermatitis have activated circulating basophils. J Allergy Clin Immunol 1993;91:1155-62.
42. Casolaro V, Spadaro G, Marone G. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma. Am Rev Respir Dis 1990;142:1108-11.
43. Djukanovic R, Mann M, Rimmer J, Spackman D, Lau L, Church MK, et al. The effect of inhaled allergen on circulating basophils in atopic asthma. J Allergy Clin Immunol 1992;90:175-83.
44. +. J Immunol 1995;155:2652-60.
45. Shalit M, Schwartz LB, von Allmen C, Atkins PC, Lauker M, Zweiman B. Release of histamine and tryptase during continuous and interrupted cutaneous challenge with allergen in humans. J Allergy Clin Immunol 1990;86:117-25.
46. MacDonald SM, Rafnar T, Langdon J, Lichtenstein LM. Molecular identification of an IgE-dependent histamine-releasing factor. Science 1995;269:688-90.
47. MacDonald SM, Schleimer RP, Kagey-Sobotka A, Gillis S, Lichtenstein LM. Recombinant IL-3 induces histamine release from human basophils. J Immunol 1989;142:3527-32.
48. Valent P, Besemer J, Muhm M, Majdic O, Lechner K, Bettelheim P. Interleukin 3 activates human blood basophils via high-affinity binding sites. Proc Natl Acad Sci USA 1989;86:5542-6.
49. Mayer P, Valent P, Schmidt G, Liehl E, Bettelheim P. The in vivo effects of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF-responsive progenitors in nonhuman primates. Blood 1989;74:613-21.
50. Haak-Frendscho M, Arai N, Arai K, Baeza ML, Finn A, Kaplan AP. Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release. J Clin Invest 1988:82:17-20.
51. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Viksman MY, Kaplan AP. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol 1992;149:636-42.
52. Alam R, Lett-Brown MA, Forsythe PA, Anderson-Walters DJ, Kenamore C, Kormos C, et al. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J Clin Invest 1992;89:723-8.
53. Kuna P, Reddigari SR, Rucinski D, Oppenheim JJ, Kaplan AP. Monocyte chemotactic and activating factor is a potent histaminereleasing factor for human basophils. J Exp Med 1992;175:489-93.
54. Bischoff SC, Krieger M, Brunner T, Dahinden CA. Monocyte chemotactic protein 1 is a potent activator of human basophils. J Exp Med 1992;175:1271-5.
55. Alam R, Forsythe PA, Lett-Brown MA, Grant JA. Interleukin-8 and RANTES inhibit basophil histamine release induced with monocyte chemotactic and activating factor/monocyte chemoattractant peptide-1 and histamine releasing factor. Am J Respir Cell Mol Biol 1992;7:427-33.
56. Weber M, Uguccioni M, Ochensberger B, Baggiolini M, Clark-Lewis I, Dahinden CA. Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J Immunol 1995;154:4166-72.
57. Dahinden CA, Geiser T, Brunner T, Von Tscharner V, Caput D, Ferrara P, et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994;179: 751-6.
58. Alam R, Forsythe PA, Stafford S, Lett-Brown MA, Grant JA. Macrophage inflammatory protein-1α activates basophils and mast cells. J Exp Med 1992;176:781-6.
59. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Sadick M, Kaplan AP. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/ chemokine family. J Immunol 1993;150:1932-43.
60. Füreder W, Agis H, Semper H, Keil F, Maier U, Müller MR, et al. Differential response of human basophils and mast cells to recombinant chemokines. Ann Hematol 1995;70:251-8.
61. Petersen LJ, Brasso K, Pryds M, Skov PS. Histamine release in intact human skin by monocyte chemoattractant factor-1, RANTES, macrophage inflammatory protein-1α, stem cell factor, anti-IgE, and codeine as determined by an ex vivo skin microdialysis technique. J Allergy Clin Immunol 1996;98:790-6.
62. El-Lati SG, Dahinden CA, Church MK. Complement peptides C3a-and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 1994;102:803-6.
63. Schulman ES, Post TJ, Henson PM, Giclas PC. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. J Clin Invest 1988;81:918-23.